About Sun Pharma Advanced Research Company Ltd
Sun Pharma Advanced Research Company is engaged in the business of research and development (R&D) of pharmaceutical products.
Founded
2006
CEO
Dilip S Shanghvi
Employees
466
HQ
Mumbai, India
Finished Products
1Other Operating Revenue
₹1,840.02Cr2Sale of Services
₹415.23Cr3Income from Operation
₹73.51Cr4Sale of Technology/know-how
₹58.73Cr5License Fees
₹15.02CrRaw Materials
1Raw material consumed
₹40.38CrAbout Sun Pharma Advanced Research Company Ltd
Sun Pharma Advanced Research Company is engaged in the business of research and development (R&D) of pharmaceutical products.
Founded:2006
CEO:Dilip S Shanghvi
Employees:466
HQ:Mumbai, India
Finished Products
1Other Operating Revenue
₹1,840.02Cr2Sale of Services
₹415.23Cr3Income from Operation
₹73.51Cr4Sale of Technology/know-how
₹58.73Cr5License Fees
₹15.02CrRaw Materials
1Raw material consumed
₹40.38CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹289
52W Low
₹108
Volume2.41M
Avg VolumeN/A
Beta1.74
Dividend Yield0.00%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
4.03x
Valuation
P/B Ratio
4.77x
Valuation
EPS
₹48.82
Valuation
Dividend Yield
0.00%
Valuation
ROE
116.01%
Profitability
ROCE
80.89%
Profitability
Revenue by Segment
Contribution & growth by business line
Pharmaceuticals Research & DevelopmRevenue split N/A
Geographical Revenue Split
Domestic vs international exposure
Domestic
97.2%
International
2.8%
Within India97.2%
Outside India2.8%
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.42x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
191.9%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.